Cargando…

The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy

PURPOSE: To examine the effect of the type and the concentration of neutron capture agents on the values of compound biological effectiveness (CBE) in boron neutron capture therapy. METHODS AND MATERIALS: After the subcutaneous administration of a (10)B-carrier, boronophenylalanine-(10)B (BPA) or so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masunaga, Shin-ichiro, Sakurai, Yoshinori, Tanaka, Hiroki, Tano, Keizo, Suzuki, Minoru, Kondo, Natsuko, Narabayashi, Masaru, Nakagawa, Yosuke, Watanabe, Tsubasa, Maruhashi, Akira, Ono, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320213/ https://www.ncbi.nlm.nih.gov/pubmed/25674433 http://dx.doi.org/10.1186/2193-1801-3-128

Ejemplares similares

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis
por: MASUNAGA, SHIN-ICHIRO, et al.
Publicado: (2014)

Evaluating the Usefulness of a Novel (10)B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2012)

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice
por: Suzuki, Minoru, et al.
Publicado: (2000)

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014)

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed (10)B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness
por: Masunaga, Shin-ichiro, et al.
Publicado: (2020)

Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis
por: Masunaga, Shin-ichiro, et al.
Publicado: (2013)

Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis
por: Masunaga, Shin-ichiro, et al.
Publicado: (2014)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Responses of Total and Quiescent Cell Populations in Solid Tumors to Boron and Gadolinium Neutron Capture Reaction Using Neutrons with Two Different Energy Spectra
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas
por: Yamatomo, Naofumi, et al.
Publicado: (2013)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine
por: Kondo, Natsuko, et al.
Publicado: (2020)

The Combined Effect of Electroporation and Borocaptate in Boron Neutron Capture Therapy for Murine Solid Tumors
por: Ono, Koji, et al.
Publicado: (2000)

Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy
por: Takeno, Satoshi, et al.
Publicado: (2022)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

Effect of Electroporation on Cell Killing by Boron Neutron Capture Therapy Using Borocaptate Sodium ((10)B‐BSH)
por: Ono, Koji, et al.
Publicado: (1998)

Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population
por: Masunaga, Shin-ichiro, et al.
Publicado: (2013)

Induced radioactivity in the blood of cancer patients following Boron Neutron Capture Therapy
por: Fujiwara, Keiko, et al.
Publicado: (2013)

Proposal for determining absolute biological effectiveness of boron neutron capture therapy—the effect of (10)B(n,α)(7)Li dose can be predicted from the nucleocytoplasmic ratio or the cell size
por: Ono, Koji, et al.
Publicado: (2019)

The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams
por: Masunaga, Shin-ichiro, et al.
Publicado: (2015)

Effects of Boron Neutron Capture Therapy Using Borocaptate Sodium in Combination with a Tumor‐selective Vasoactive Agent in Mice
por: Ono, Koji, et al.
Publicado: (1998)

ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019)

Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture Reaction
por: Tatebe, Hitoshi, et al.
Publicado: (2020)

Effect of Tirapazamine, Metformin or Mild Hyperthermia on Recovery From Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cells
por: Masunaga, Shin-ichiro, et al.
Publicado: (2017)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma
por: Fujita, Yusei, et al.
Publicado: (2009)

Improvement in the neutron beam collimation for application in boron neutron capture therapy of the head and neck region
por: Hu, Naonori, et al.
Publicado: (2022)

Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy
por: Hattori, Yoshihide, et al.
Publicado: (2023)

DNA double-strand break induction in Ku80-deficient CHO cells following Boron Neutron Capture Reaction
por: Kinashi, Yuko, et al.
Publicado: (2011)

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy
por: Watanabe, Tsubasa, et al.
Publicado: (2016)

Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry
por: Flieger, Sebastian, et al.
Publicado: (2023)

Development of optimization method for uniform dose distribution on superficial tumor in an accelerator-based boron neutron capture therapy system
por: Sasaki, Akinori, et al.
Publicado: (2023)

Conference on Accelerator-based Neutron Sources for Boron Neutron Capture Therapy
Publicado: (1994)

Neutron Tube Design Study for Boron Neutron Capture Therapy Application
por: Verbeke, J M, et al.
Publicado: (1999)

Microdosimetric quantities of an accelerator-based neutron source used for boron neutron capture therapy measured using a gas-filled proportional counter
por: Hu, Naonori, et al.
Publicado: (2020)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kbvpbh9rko1i079gufcsgl4qkt